Early research (Phase 1)WithdrawnNCT03231475What this trial is testingPhase I Study of SPH1188-11 in NSCLCWho this might be right forNSCLC Stage IIIBNSCLC Stage IV Shanghai Pharmaceuticals Holding Co., Ltd
Testing effectiveness (Phase 2)Study completedNCT01935336What this trial is testingStudy of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive BiomarkersWho this might be right forAdenocarcinoma of the LungExtensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung Cancer+5 more University of Colorado, Denver 171
Early research (Phase 1)Active Not RecruitingNCT04197934What this trial is testingWSD0922-FU for Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System MetastasesWho this might be right forAnaplastic Astrocytoma, IDH-WildtypeGlioblastoma, IDH-WildtypeMetastatic Lung Non-Small Cell Carcinoma+2 more Mayo Clinic 56
Early research (Phase 1)Not Yet RecruitingNCT07798921What this trial is testingJIN-A02 Plus Amivantamab in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI FailureWho this might be right forCarcinomaNon-Small-Cell Lung Yonsei University 36
Early research (Phase 1)Looking for participantsNCT07646106What this trial is testingTHE-0504 in Patients With Solid TumorsWho this might be right forSmall Cell Lung Cancer (SCLC)Colorectal Carcinoma (CRC)Gastric Cancer (GC)+2 more Thena Biotech S.r.l. 30
Testing effectiveness (Phase 2)Study completedNCT00077415What this trial is testing3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung CancerWho this might be right forLung Cancer Cancer Therapeutics Research Group 31
Not applicableUnknownNCT06321640What this trial is testingStudy for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.Who this might be right forBreast CancerLung CancerMelanoma+5 more European Institute of Oncology 265
Early research (Phase 1)Not Yet RecruitingNCT06941480What this trial is testing177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and ProstateWho this might be right forNeuroendocrine Tumor of the LungNeuroendocrine Carcinoma of LungNeuroendocrine Carcinoma+1 more Memorial Sloan Kettering Cancer Center 12
Not applicableEnded earlyNCT05304390What this trial is testingA Tailored Screening and Smoking Cessation Program for the LGBTQ Community of SeattleWho this might be right forLung Carcinoma Fred Hutchinson Cancer Center 53
Early research (Phase 1)Study completedNCT01155258What this trial is testingTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsWho this might be right forExtensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more University of Southern California 19
Testing effectiveness (Phase 2)Ended earlyNCT02949843What this trial is testingTargeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic MutationsWho this might be right forEGFR Activating MutationRecurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer Wake Forest University Health Sciences 19
Testing effectiveness (Phase 2)UnknownNCT05810350What this trial is testingAumolertinib Combined Intrathecal Chemotherapy for Leptomeningeal Metastasis From EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA ProfilesWho this might be right forNon-small Cell Lung Cancer Three Gorges Hospital of Chongqing University 40
Early research (Phase 1)Study completedNCT02076620What this trial is testingL19TNFα in Combination With Doxorubicin in Patients With Advanced Solid TumoursWho this might be right forAdvanced Solid Tumors Amenable to Anthracycline TherapySarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy Philogen S.p.A. 29
Early research (Phase 1)UnknownNCT06384482What this trial is testingSNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine CarcinomaWho this might be right forRecurrent/Refractory Small Cell Lung Cancer Lung Large Cell Neuroendocrine Carcinoma Shanghai Simnova Biotechnology Co.,Ltd. 35
Early research (Phase 1)Study completedNCT01668823What this trial is testingPhotodynamic Therapy in Treating Patients With Lung CancerWho this might be right forAdenocarcinoma of the LungLarge Cell Lung CancerRecurrent Non-small Cell Lung Cancer+2 more Roswell Park Cancer Institute 17
Not applicableStudy completedNCT02250755What this trial is testingMRI Perfusion on T1 and T2 Brain Lesion(s)Who this might be right forLung Carcinoma Metastatic to the Brain University Hospital, Lille 30
Not applicableUnknownNCT05736991What this trial is testingDeep Learning Signature for Predicting the Novel Grading System of Clinical Stage I Lung AdenocarcinomaWho this might be right forLung AdenocarcinomaRadiomicsGrading System Shanghai Pulmonary Hospital, Shanghai, China 600
Testing effectiveness (Phase 2)Study completedNCT01218516What this trial is testingA Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the LungWho this might be right forAdenocarcinoma of the Lung Morphotek 130
Testing effectiveness (Phase 2)UnknownNCT04312204What this trial is testingClinical Trial of Sintilimab Combined With Gemcitabine/Carboplatin Regimen in the Treatment of Advanced Primary Pulmonary Lymphoepithelioma-like CarcinomaWho this might be right forPrimary Pulmonary Lymphoepithelioma-like CarcinomaLung Cancer Zhou Chengzhi 30
Very early researchLooking for participantsNCT05493566What this trial is testingLow-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung CancerWho this might be right forLung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+1 more Emory University 15